Total compensation · 2025
$27.6M
$27,585,301 as reported in Pfizer Inc.'s proxy statement.
Names, titles and pay as reported by the company and its SEC filings, via Financial Modeling Prep. Reference only — nothing here is investment advice, and no affiliation with or endorsement by the people listed is implied.
| Year |
|---|
| Salary |
|---|
| Stock awards |
|---|
| Option awards |
|---|
| Incentive plan |
|---|
| Other |
|---|
| Total |
|---|
| Filing |
|---|
| 2025 | $1.8M | $9.4M | $9M | $5.4M | $1.9M | $27.6M | SEC |
| 2024 | $1.8M | $4.8M | $10M | $7M | $996.1K | $24.6M | SEC |
| 2023 | $1.8M | $8.7M | $8.8M | $0 | $2.3M | $21.6M | SEC |
| 2022 | $1.7M | $9.3M | $9.5M | $7.7M | $4.8M | $33M | SEC |
| 2021 | $1.7M | $6.2M | $7.1M | $8M | $1.4M | $24.4M | SEC |
| 2020 | $1.7M | $4.9M | $6.8M | $5.5M | $2.2M | $21M | SEC |
| 2019 | $1.6M | $4.3M | $6.1M | $3.6M | $2.3M | $17.9M | SEC |
| 2018 | $1.4M | $2.6M | $4M | $1.5M | $375.1K | $9.9M | SEC |
| 2017 | $1.2M | $1.7M | $1.8M | $1.3M | $3M | $8.8M | SEC |
| 2016 | $1.1M | $936.9K | $1.8M | $1.8M | $3.2M | $8.9M | SEC |
Medicus Pharma CEO on SkinJect and Pfizer partnership – ICYMI
Sep 12, 2026https://www.proactiveinvestors.com/companies/news/1098450sentiment +0.10
Novavax Highlights Matrix-M Licensing Push, Oncology Ambitions at Cantor Conference
Sep 10, 2026https://www.marketbeat.com/instant-alerts/event-novavax-highlights-matrix-m-licensing-push-oncology-ambitions-at-cantor-conference-2026-09-10/sentiment +0.20
Pfizer's Stock Has Been Crushed—Is Its 6% Dividend Finally Worth Buying?
Sep 4, 2026https://247wallst.com/investing/2026/09/04/pfizers-stock-has-been-crushed-is-its-6-dividend-finally-worth-buying/sentiment -0.40
5 Reasons To Buy Clinuvel Pharmaceuticals After Its Nasdaq Uplisting
Sep 2, 2026https://seekingalpha.com/article/4942443-5-reasons-to-buy-clinuvel-pharmaceuticals-after-its-nasdaq-uplistingsentiment -0.20
Should Eli Lilly Investors Be Worried About a Threat From Amylyx?
Aug 30, 2026https://www.fool.com/investing/2026/08/30/should-eli-lilly-investors-be-worried-about-a-thre/sentiment +0.10
Moderna's Newfound War Chest Opens Door for 4 Strategic Acquisition Targets
Aug 20, 2026https://247wallst.com/investing/2026/08/20/modernas-newfound-war-chest-opens-door-for-4-strategic-acquisition-targets/sentiment -0.20
